Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies

被引：0
|
作者：
Macaluso, F. S. [1 ]
Ventimiglia, M. [2 ]
Orlando, A. [1 ]
机构：
[1] Villa Sofia Cervello Hosp, IBD Unit, Palermo, Italy
[2] Italian Minist Hlth, Directorate Gen Med Device & Pharmaceut Serv, Rome, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P727
引用
收藏
页码：857 / 858
页数：2
相关论文
共 50 条
  • [21] Effectiveness and safety of Ustekinumab in patients with inflammatory bowel disease from the real-world study: A systematic review with meta-analysis of observational studies
    Zhou, He
    Wang, Fang
    Su, Song
    Shi, Yanting
    Wu, Tong
    Liang, Jie
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 88 - 88
  • [22] Effectiveness and safety of Ustekinumab in patients with inflammatory bowel disease from the real-world study: A systematic review with meta-analysis of observational studies
    Zhou, He
    Wang, Fang
    Su, Song
    Shi, Yanting
    Wu, Tong
    Liang, Jie
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 88 - 88
  • [23] Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study
    Ruth Garcia-Romero
    José Miguel Martinez de Zabarte Fernandez
    Gemma Pujol-Muncunill
    Ester Donat-Aliaga
    Oscar Segarra-Cantón
    Iñaki Irastorza-Terradillos
    Enrique Medina-Benitez
    Carlos José Ruiz-Hernández
    Marta Carrillo-Palau
    Ignacio Ros-Arnal
    Alejandro Rodriguez-Martínez
    Laura Escartin-Madurga
    Carolina Gutiérrez-Junquera
    Saioa Vicente-Santamaría
    Marta Velasco Rodriguez-Belvis
    Sonia Fernández-Fernández
    José Ramón Alberto-Alonso
    Montserrat Montraveta
    Ricardo Torres-Peral
    María Navalon-Rubio
    Víctor Manuel Navas-López
    Javier Martin de Carpi
    European Journal of Pediatrics, 2021, 180 : 3039 - 3040
  • [24] Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease
    Yung, Diana E.
    Horesh, Nir
    Lightner, Amy L.
    Ben-Horin, Shomron
    Eliakim, Rami
    Koulaouzidis, Anastasios
    Kopylov, Uri
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2327 - 2338
  • [25] A posteriori dietary patterns and risk of inflammatory bowel disease: a meta-analysis of observational studies
    Khorshidi, Masoud
    Djafarian, Kurosh
    Aghayei, Elham
    Shab-Bidar, Sakineh
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2020, 90 (3-4) : 376 - 384
  • [26] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [27] Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis
    Jin, Yu
    Lin, Yan
    Lin, Lian-Jie
    Zheng, Chang-Qing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (20) : 6352 - 6360
  • [28] Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Peyrin-Biroulet, Laurent
    Arkkila, Perttu
    Armuzzi, Alessandro
    Danese, Silvio
    Guardiola, Jordi
    Jahnsen, Jorgen
    Lees, Charles
    Louis, Edouard
    Lukas, Milan
    Reinisch, Walter
    Roblin, Xavier
    Jang, Minyoung
    Byun, Han Geul
    Kim, Dong-Hyeon
    Lee, Sung Jeong
    Atreya, Raja
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [29] Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Laurent Peyrin-Biroulet
    Perttu Arkkila
    Alessandro Armuzzi
    Silvio Danese
    Jordi Guardiola
    Jørgen Jahnsen
    Charles Lees
    Edouard Louis
    Milan Lukáš
    Walter Reinisch
    Xavier Roblin
    Minyoung Jang
    Han Geul Byun
    Dong-Hyeon Kim
    Sung Jeong Lee
    Raja Atreya
    BMC Gastroenterology, 22
  • [30] Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis
    Yu Jin
    Yan Lin
    Lian-Jie Lin
    Chang-Qing Zheng
    World Journal of Gastroenterology, 2015, (20) : 6352 - 6360
12345